Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Hosaka

Showing results (71-80 of 306) with videos related to

Pageof 31
Sort By:
Journal of Gastroenterology and Hepatology|August 21, 2008
Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitisYusuke Kawamura, Kenji Ikeda, Yasuji Arase, et al.
Hepatology (Baltimore, Md.)|January 8, 2009
Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis CYasuji Arase, Fumitaka Suzuki, Yoshiyuki Suzuki, et al.
Internal Medicine (Tokyo, Japan)|November 11, 2003
A pilot study of thymosin alpha1 therapy for chronic hepatitis B patientsYasuji Arase, Akihito Tsubota, Yoshiyuki Suzuki, et al.
Journal of Hepatology|February 15, 2003
The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatmentNorio Akuta, Fumitaka Suzuki, Mariko Kobayashi, et al.
Intervirology|July 19, 2005
Usefulness of the serum KL-6 assay in patients with hepatitis C virusYasuji Arase, Kenji Ikeda, Fumitaka Suzuki, et al.
Journal of Gastroenterology|August 5, 2004
Factors contributing to ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis CShintaro Takaki, Akihito Tsubota, Tetsuya Hosaka, et al.
Journal of Medical Virology|June 14, 2008
Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapyNorio Akuta, Fumitaka Suzuki, Yusuke Kawamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 30, 2008
Potential of laparoscopy in chronic liver disease with hepatitis B and C virusesYasuji Arase, Fumitaka Suzuki, Yoshiyuki Suzuki, et al.
Intervirology|November 27, 2004
Adefovir dipivoxil for treatment of breakthrough hepatitis caused by lamivudine-resistant mutants of hepatitis B virusTetsuya Hosaka, Fumitaka Suzuki, Yoshiyuki Suzuki, et al.
The American Journal of Medicine|January 25, 2006
Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis BYasuji Arase, Kenji Ikeda, Fumitaka Suzuki, et al.
Pageof 31

Showing results (71-80 of 306) with videos related to

Sort By:
Pageof 31
Journal of Gastroenterology and Hepatology|August 21, 2008
Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitisYusuke Kawamura, Kenji Ikeda, Yasuji Arase, et al.
Hepatology (Baltimore, Md.)|January 8, 2009
Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis CYasuji Arase, Fumitaka Suzuki, Yoshiyuki Suzuki, et al.
Internal Medicine (Tokyo, Japan)|November 11, 2003
A pilot study of thymosin alpha1 therapy for chronic hepatitis B patientsYasuji Arase, Akihito Tsubota, Yoshiyuki Suzuki, et al.
Journal of Hepatology|February 15, 2003
The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatmentNorio Akuta, Fumitaka Suzuki, Mariko Kobayashi, et al.
Intervirology|July 19, 2005
Usefulness of the serum KL-6 assay in patients with hepatitis C virusYasuji Arase, Kenji Ikeda, Fumitaka Suzuki, et al.
Journal of Gastroenterology|August 5, 2004
Factors contributing to ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis CShintaro Takaki, Akihito Tsubota, Tetsuya Hosaka, et al.
Journal of Medical Virology|June 14, 2008
Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapyNorio Akuta, Fumitaka Suzuki, Yusuke Kawamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 30, 2008
Potential of laparoscopy in chronic liver disease with hepatitis B and C virusesYasuji Arase, Fumitaka Suzuki, Yoshiyuki Suzuki, et al.
Intervirology|November 27, 2004
Adefovir dipivoxil for treatment of breakthrough hepatitis caused by lamivudine-resistant mutants of hepatitis B virusTetsuya Hosaka, Fumitaka Suzuki, Yoshiyuki Suzuki, et al.
The American Journal of Medicine|January 25, 2006
Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis BYasuji Arase, Kenji Ikeda, Fumitaka Suzuki, et al.
Pageof 31